Summary
Suven Life Sciences Ltd (Suven), formerly Suven Pharmaceuticals Pvt. Ltd. is a biopharmaceutical company that designs, manufactures and supplies bulk actives, drug intermediates and fine chemicals. The company provides products through the divisions API, and intermediates. Its API products include aripiprazole, calcium acetate, divalproex sodium, entacapone, fenoprofen calcium, gabapentin, glycopyrrolate, and others. Suven provides iron sucrose complex for injection, losartan potassium, malathion lotion, nitazoxanide, pamabrom, sodium ferric gluconate for injection, verapamil hydrochoride and zolmitriptan. The company’s intermediates include diethyl amino cyanoacetamide, 3,4-dihydroxy-5-nitrobenzaldehyde, 1,2,3-triacetoxy -5-deoxyribose, and 1-(4-chlorophenyl)-cyclobutanecarbonitrile. Suven offers products in the form of solutions, suspensions, emulsions, injectables, lyophilized formulations, ophthalmic and aural preparations, ointments, creams and gels. It has presence in the US, Australia, India and New Zealand. Suven is headquartered in Hyderabad, Telangana, India.
Suven Life Sciences Ltd (SUVEN) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.
Scope
- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.
Reasons to Buy
Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
'
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Suven Life Sciences Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 5
Suven Life Sciences Ltd, Pharmaceuticals & Healthcare Deals By Type, 2010 to YTD 2016 6
Suven Life Sciences Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 7
Suven Life Sciences Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016 8
Suven Life Sciences Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2010 to YTD 2016 9
Suven Life Sciences Ltd, Pharmaceuticals & Healthcare, Deal Details 10
Licensing Agreements 10
Suven Life Science Enters Into Licensing Agreement With Taro Pharma To Market Malathion Lotion 10
Equity Offering 11
Suven Life Sciences Raises USD32.3 Million in Private Placement of Shares 11
Suven Life Sciences Announces Public Offering Of Shares For US$20 Million 13
Suven Life Sciences Ltd - Key Competitors 15
Key Employees 16
Locations And Subsidiaries 17
Head Office 17
Other Locations & Subsidiaries 17
Appendix 18
Methodology 18
About GlobalData 18
Contact Us 18
Disclaimer 18
List of Tables
Suven Life Sciences Ltd, Pharmaceuticals & Healthcare, Key Facts, 2016 1
Suven Life Sciences Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 5
Suven Life Sciences Ltd, Pharmaceuticals & Healthcare Deals By Type, 2010 to YTD 2016 6
Suven Life Sciences Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 7
Suven Life Sciences Ltd, Deals By Therapy Area, 2010 to YTD 2016 8
Suven Life Sciences Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2010 to YTD 2016 9
Suven Life Science Enters Into Licensing Agreement With Taro Pharma To Market Malathion Lotion 10
Suven Life Sciences Raises USD32.3 Million in Private Placement of Shares 11
Suven Life Sciences Announces Public Offering Of Shares For US$20 Million 13
Suven Life Sciences Ltd, Key Competitors 15
Suven Life Sciences Ltd, Key Employees 16
Suven Life Sciences Ltd, Other Locations 17
Suven Life Sciences Ltd, Subsidiaries 17
List of Figures
Suven Life Sciences Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016 1
Suven Life Sciences Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 1
Suven Life Sciences Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 1
Suven Life Sciences Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016 1
Suven Life Sciences Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 5
Suven Life Sciences Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016 6
Suven Life Sciences Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 7
Suven Life Sciences Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016 8